To explain the traits of the inhabitants attended within the medical psychology programme in Major Care, in addition to to carry out a preliminary evaluation of the outcomes obtained.Potential, descriptive examine of the outcomes obtained after transient psychological intervention. The next analysis instruments had been used: PHQ-9, GAD-7, WHOQOL-BREF, and an advert hoc designed satisfaction questionnaire.A complete of 1084 sufferers had been referred to this system, and had been largely girls. Essentially the most frequent diagnoses had been anxiousness, adaptive problems, Zcodes (elements that affect the state of well being and speak to with well being companies) and depressive problems. The imply ready record time was 7.25days, and the imply variety of consultations was3.

The analyses carried out after the remedy confirmed an enchancment in all of the variables evaluated, in addition to excessive satisfaction and usefulness of the remedy.The mixing of the medical psychologist in Major Care results in an enchancment within the high quality of care of sufferers with emotional problems, facilitating an interdisciplinary bio-psycho-social strategy, and providing internationally really useful evidence-based remedies and interventions. This text presents a present (as of September 2019) record of really useful ages for confirmed terrestrial affect constructions (n = 200) and deposits (n = 46) sourced from the first literature. Excessive-precision affect ages can be utilized to (1) reconstruct and quantify the affect flux within the internal Photo voltaic System and, particularly, the Earth-Moon system, thereby putting constraints on the supply of extraterrestrial mass accreted on Earth via geologic time; (2) make the most of affect ejecta as occasion markers within the stratigraphic report and to refine bio– and magneto-stratigraphy; (3) check fashions and hypotheses of synchronous double or a number of affect occasions within the terrestrial report; (4) assess the potential hyperlink between giant impacts, mass extinctions, and diversification occasions within the biosphere; and (5) constrain the period of soften sheet crystallization in giant affect basins and the lifetime of hydrothermal programs in cooling affect craters, which can have served as habitats for microbial life on the early Earth and, presumably, Mars. Bio-based industries rely extensively on using enzymatic biocatalysts.

The worldwide marketplace for industrial enzymes, of which roughly half is used for meals functions, is estimated at $5.5 billion. Most enzymes utilized in meals manufacturing worldwide are produced by recombinant DNA methods. Manufacturing and use of meals enzymes are regulated by three fundamental our bodies: the Joint Meals and Agriculture Group of the United Nations/World Well being Group Skilled Committee on Meals Components; the European Meals Security Authority; and the U.S. Meals and Drug Administration

 

Addition of Isocyanide-containing Amino Acids to the Genetic Code for Protein Labeling and Activation.

Website-specific introduction of bioorthogonal handles into bio-molecules gives highly effective instruments for learning and manipulating the constructions and features of proteins. Current advances in bioorthogonal chemistry show that tetrazine-based bioorthogonal cycloaddition is a par-ticularly helpful methodology attributable to its excessive reactivity, biological selectivity, and turn-on property for fluores-cence imaging. Regardless of its broad functions in protein labeling and imaging, utilization of tetrazine-based bioorthogonal cycloaddition has been restricted thus far by the requirement of a hydrophobic strained alkene reactive moiety.
Circumventing this structural requirement, we report the site-specific incorporation of noncanonical ami-no acids (ncAAs) with a small isocyanide (or isonitrile) group into proteins in each bacterial and mammalian cells. We confirmed that, underneath physiological circumstances and within the absence of a catalyst, these isocyanide-containing ncAAs may react selectively with tetrazine molecules by way of [4+1]-cycloaddition, thus offering a flexible bioorthog-onal deal with for site-specific protein labeling and protein decaging. Considerably, these bioorthogonal reactions between isocyanides and tetrazines additionally present a novel mechanism for the activation of tetrazine-quenched fluoro-phores.
The addition of those isocyanide-containing ncAAs to the record of 20 commonly-used, naturally occurring amino acids expands our repertoire of reagents for bioorthogonal chemistry, due to this fact enabling new biological functions starting from protein labeling and imaging research to the chemical activation of proteins.

Acoustically responsive polydopamine nanodroplets: A novel theranostic agent.

Ultrasound-induced cavitation has been used as a device of enhancing extravasation and tissue penetration of anticancer brokers in tumours. Initiating cavitation in tissue nonetheless, requires excessive acoustic intensities which can be neither protected nor straightforward to realize with present medical programs. The usage of cavitation nuclei can nonetheless decrease the acoustic intensities required to provoke cavitation and the ensuing bio-effects in situ. Microbubbles, strong gas-trapping nanoparticles, and part shift nanodroplets are some examples in a rising record of proposed cavitation nuclei.
In addition to the flexibility to decrease the cavitation threshold, stability, lengthy circulation occasions, biocompatibility and biodegradability, are a number of the fascinating traits {that a} clinically relevant cavitation agent ought to possess. On this examine, we current a novel formulation of ultrasound-triggered part transition sub-micrometer sized nanodroplets (~400 nm) stabilised with a biosuitable polymer, polydopamine (PDA). PDA provides some vital advantages: (1) facile fabrication, as dopamine monomers are immediately polymerised on the nanodroplets, (2) excessive polymer biocompatibility, and (3) ease of functionalisation with different molecules similar to medication or concentrating on species.

Lambda Light Chain Antibody / Lambda Antibody

R20179BTN-50UG 50ug
EUR 409

Lambda Light Chain Antibody / Lambda Antibody

R20179SAF-250UG 250ug
EUR 979

Lambda Light Chain Antibody / Lambda Antibody

RQ4975 100ul
EUR 419

Lambda Light Chain Antibody / Lambda Antibody

V9032-100UG 100 ug
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V9032-20UG 20 ug
EUR 219
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V9032IHC-7ML 7 ml
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V9032SAF-100UG 100 ug
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3151-100UG 100 ug
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3151-20UG 20 ug
EUR 219
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3151CF488-100T 100 Tests
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3151IHC-7ML 7 ml
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3151SAF-100UG 100 ug
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3152-100UG 100 ug
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3152-20UG 20 ug
EUR 219
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3152SAF-100UG 100 ug
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3261-100UG 100 ug
EUR 499
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm.

Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki]

Lambda Light Chain Antibody / Lambda Antibody

V3261-20UG 20 ug
EUR 219
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm.

Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki]

Lambda Light Chain Antibody / Lambda Antibody

V3261SAF-100UG 100 ug
EUR 499
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm.

Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki]

Lambda Light Chain Antibody / Lambda Antibody

V3262-100UG 100 ug
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3262-20UG 20 ug
EUR 219
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V3262SAF-100UG 100 ug
EUR 499
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V2151-100UG 100 ug
EUR 499
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V2151-20UG 20 ug
EUR 219
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V2151SAF-100UG 100 ug
EUR 499
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V2153-100UG 100 ug
EUR 499
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V2153-20UG 20 ug
EUR 219
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V2153CF488-100T 100 Tests
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V2153IHC-7ML 7 ml
EUR 499
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V2153SAF-100UG 100 ug
EUR 499
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V7875-100UG 100 ug
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V7875-20UG 20 ug
EUR 219
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V7875SAF-100UG 100 ug
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V7878-100UG 100 ug
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V7878-20UG 20 ug
EUR 219
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V7878SAF-100UG 100 ug
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V7879-100UG 100 ug
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V7879-20UG 20 ug
EUR 219
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody / Lambda Antibody

V7879SAF-100UG 100 ug
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light chain Antibody

43108-100ul 100ul
EUR 302.4

lambda light chain Antibody

abx034778-400ul 400 ul
EUR 627.6

lambda light chain Antibody

abx034778-80l 80 µl
EUR 343.2

Lambda Light chain Antibody

DF14068 100ul
EUR 420

Lambda Light Chain Antibody

V8873-100UG 100ug
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody

V8873-20UG 20ug
EUR 219
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain Antibody

V8873SAF-100UG 100ug
EUR 499
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.

Lambda Light Chain (Lambda-IgLC) Antibody

abx413204-02mg 0.2 mg
EUR 678

Lambda Light Chain (Lambda-IgLC) Antibody

abx414083-025mg 0.25 mg
EUR 678

Lambda Light Chain (Lambda-IgLC) Antibody

abx415391-01mg 0.1 mg
EUR 610.8

Lambda Light Chain (Lambda-IgLC) Antibody

abx415790-1mg 1 mg
EUR 526.8

Lambda Light Chain (Lambda-IgLC) Antibody

abx415793-05mg 0.5 mg
EUR 477.6

Lambda Light Chain (Lambda-IgLC) Antibody

abx415798-1mg 1 mg
EUR 661.2

Lambda Light Chain (Lambda-IgLC) Antibody

abx415800-05mg 0.5 mg
EUR 477.6

Lambda Light Chain (Lambda-IgLC) Antibody

abx411151-1mg 1 mg
EUR 661.2

Lambda Light Chain (Lambda-IgLC) Antibody

abx411423-05mg 0.5 mg
EUR 794.4

Lambda Light Chain (Lambda-IgLC) Antibody (FITC)

abx413205-01mg 0.1 mg
EUR 610.8

Lambda Light Chain (Lambda-IgLC) Antibody (RPE)

abx413206-100tests 100 tests
EUR 710.4

Lambda Light Chain (Lambda-IgLC) Antibody (HRP)

abx414084-025mg 0.25 mg
EUR 710.4

Lambda Light Chain (Lambda-IgLC) Antibody (FITC)

abx415791-1mg 1 mg
EUR 560.4

Lambda Light Chain (Lambda-IgLC) Antibody (HRP)

abx415792-1ml 1 ml
EUR 594

Lambda Light Chain (Lambda-IgLC) Antibody (FITC)

abx415794-05mg 0.5 mg
EUR 526.8

Lambda Light Chain (Lambda-IgLC) Antibody (HRP)

abx415795-1ml 1 ml
EUR 594

Lambda Light Chain (Lambda-IgLC) Antibody (RPE)

abx415796-05ml 0.5 ml
EUR 760.8

Lambda Light Chain (Lambda-IgLC) Antibody (FITC)

abx411152-1mg 1 mg
EUR 811.2

Lambda Light Chain (Lambda-IgLC) Antibody (TRITC)

abx411153-05mg 0.5 mg
EUR 526.8

Lambda Light Chain (Lambda-IgLC) Antibody (AP)

abx411154-1ml 1 ml
EUR 678

Lambda Light Chain (Lambda-IgLC) Antibody (HRP)

abx411155-1ml 1 ml
EUR 594

Lambda Light Chain (Lambda-IgLC) Antibody (Biotin)

abx411156-1mg 1 mg
EUR 727.2

Lambda Light Chain (Lambda-IgLC) Antibody (TRITC)

abx411220-1mg 1 mg
EUR 560.4

Lambda Light Chain (Lambda-IgLC) Antibody (Biotin)

abx411222-1mg 1 mg
EUR 594

Lambda Light Chain (Lambda-IgLC) Antibody (RPE)

abx411223-05mg 0.5 mg
EUR 927.6

Human Lambda Light Chain

7-05497 200µg Ask for price

Human Lambda Light Chain

7-05498 1mg Ask for price

Human Lambda Light Chain

7-05499 10mg Ask for price

Rabbit Lambda light chain antibody

70R-10680 1 ml
EUR 417.6
Description: Rabbit polyclonal Lambda light chain antibody

Ig lambda Light Chain Antibody

20-abx137078
  • EUR 427.20
  • EUR 627.60
  • 0.5 mg
  • 1 mg

Free lambda Light Chain Antibody

abx023820-1mg 1 mg
EUR 718.8

Lambda Light Chain(HP6054) Antibody

BNC040262-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF405S conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC040262-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF405S conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC040636-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF405S conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC040636-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF405S conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC040860-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF405S conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC040860-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF405S conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC050262-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF405M conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC050262-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF405M conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC050636-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF405M conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC050636-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF405M conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC050860-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF405M conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC050860-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF405M conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNCAP0262-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(HP6054), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNCAP0262-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(HP6054), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNCAP0636-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(LAM03), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNCAP0636-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(LAM03), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNCAP0860-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(Lamb14), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNCAP0860-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(Lamb14), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNCB0262-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(HP6054), Biotin conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNCB0262-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(HP6054), Biotin conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNCB0636-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(LAM03), Biotin conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNCB0636-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(LAM03), Biotin conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNCB0860-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(Lamb14), Biotin conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNCB0860-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(Lamb14), Biotin conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNCP0262-250 250uL
EUR 459.6
Description: Primary antibody against Lambda Light Chain(HP6054), PerCP conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNCP0636-250 250uL
EUR 459.6
Description: Primary antibody against Lambda Light Chain(LAM03), PerCP conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNCP0860-250 250uL
EUR 459.6
Description: Primary antibody against Lambda Light Chain(Lamb14), PerCP conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNCR0262-250 250uL
EUR 459.6
Description: Primary antibody against Lambda Light Chain(HP6054), RPE conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNCR0636-250 250uL
EUR 459.6
Description: Primary antibody against Lambda Light Chain(LAM03), RPE conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNCR0860-250 250uL
EUR 459.6
Description: Primary antibody against Lambda Light Chain(Lamb14), RPE conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC940262-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF594 conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC940262-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF594 conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC940636-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF594 conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC940636-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF594 conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC940860-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF594 conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC940860-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF594 conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNCA0262-250 250uL
EUR 459.6
Description: Primary antibody against Lambda Light Chain(HP6054), APC conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNCA0636-250 250uL
EUR 459.6
Description: Primary antibody against Lambda Light Chain(LAM03), APC conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNCA0860-250 250uL
EUR 459.6
Description: Primary antibody against Lambda Light Chain(Lamb14), APC conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC810262-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF680R conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC810262-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF680R conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC810636-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF680R conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC810636-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF680R conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC810860-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF680R conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC810860-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF680R conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNUB0262-100 100uL
EUR 250.8
Description: Primary antibody against Lambda Light Chain(HP6054), Concentration: 0.2mg/mL

Lambda Light Chain(HP6054) Antibody

BNUB0262-500 500uL
EUR 549.6
Description: Primary antibody against Lambda Light Chain(HP6054), Concentration: 0.2mg/mL

Lambda Light Chain(LAM03) Antibody

BNUB0636-100 100uL
EUR 250.8
Description: Primary antibody against Lambda Light Chain(LAM03), Concentration: 0.2mg/mL

Lambda Light Chain(LAM03) Antibody

BNUB0636-500 500uL
EUR 549.6
Description: Primary antibody against Lambda Light Chain(LAM03), Concentration: 0.2mg/mL

Lambda Light Chain(Lamb14) Antibody

BNUB0860-100 100uL
EUR 250.8
Description: Primary antibody against Lambda Light Chain(Lamb14), Concentration: 0.2mg/mL

Lambda Light Chain(Lamb14) Antibody

BNUB0860-500 500uL
EUR 549.6
Description: Primary antibody against Lambda Light Chain(Lamb14), Concentration: 0.2mg/mL

Lambda Light Chain(HP6054) Antibody

BNCH0262-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(HP6054), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNCH0262-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(HP6054), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNCH0636-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(LAM03), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNCH0636-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(LAM03), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNCH0860-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(Lamb14), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNCH0860-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(Lamb14), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC880262-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF488A conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC880262-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF488A conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC880636-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF488A conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC880636-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF488A conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC880860-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF488A conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(Lamb14) Antibody

BNC880860-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(Lamb14), CF488A conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC680262-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF568 conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(HP6054) Antibody

BNC680262-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(HP6054), CF568 conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC680636-100 100uL
EUR 238.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF568 conjugate, Concentration: 0.1mg/mL

Lambda Light Chain(LAM03) Antibody

BNC680636-500 500uL
EUR 652.8
Description: Primary antibody against Lambda Light Chain(LAM03), CF568 conjugate, Concentration: 0.1mg/mL
We show that the acoustic intensities required to provoke inertial cavitation can all be achieved with present medical ultrasound programs. Cell viability and haemolysis research present that nanodroplets are biosuitable. Our outcomes show the good potential of PDA nanodroplets as an acoustically lively nanodevice, which is very priceless for biomedical functions together with drug supply and remedy monitoring.



Leave a Reply

Your email address will not be published.